OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MODD$3.4656

Modular Medical Inc

Medical Equipment, Supplies & DistributionVerified

Modular Medical Inc has a strong liquidity position, with a current ratio of 6.66, indicating that it holds significantly more current assets than current liabilities. The company's cash and equivalents amount to $9.23 million, which is a substantial portion of its total assets of $13.81 million. The company's price-to-book ratio is 1.62, suggesting that the market values the company at a premium to its book value. However, the company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The company's profitability metrics are negative, with a return on equity of -37.11% and a return on assets of -31.01%, which are below the industry median for medical equipment and supplies companies. The operating income and net income are both negative, at -$4.32 million and -$4.28 million, respectively. The company's operating cash flow is also negative at -$13.95 million, indicating that it is not generating sufficient cash from operations to sustain its activities. Modular Medical Inc's revenue is concentrated in a single business segment, as disclosed in its financial statements. The company does not provide detailed geographic revenue breakdowns, but its operations are primarily based in the United States. The lack of geographic diversification may expose the company to regional economic and regulatory risks. The company's growth trajectory is uncertain, as it has not provided specific revenue growth projections for the current or next fiscal year. The company's free cash flow is negative at -$4.62 million, and its capital expenditures are -$1.70 million, indicating that it is not investing in new projects or expanding its operations. The company's shares outstanding are the same for both basic and diluted shares, at 5.41 million, suggesting that there is no significant dilution risk from stock options or convertible securities. The company's risk assessment indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected. The company's liquidity position is strong, with a high current ratio and significant cash reserves. However, the company's negative operating and net income, along with its negative operating cash flow, may raise concerns about its long-term financial sustainability. The company has not made any recent public filings or disclosures that would indicate significant changes in its business or financial condition.

30-day price · MODD(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyModular Medical Inc
TickerMODD.O
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Modular Medical Inc is a medical equipment and supplies company that provides modular solutions for healthcare facilities, primarily generating revenue through the sale of its products and services.

Classification. Modular Medical Inc is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Modular Medical Inc has a strong liquidity position, with a current ratio of 6.66, indicating that it holds significantly more current assets than current liabilities. The company's cash and equivalents amount to $9.23 million, which is a substantial portion of its total assets of $13.81 million. The company's price-to-book ratio is 1.62, suggesting that the market values the company at a premium to its book value. However, the company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. The company's profitability metrics are negative, with a return on equity of -37.11% and a return on assets of -31.01%, which are below the industry median for medical equipment and supplies companies. The operating income and net income are both negative, at -$4.32 million and -$4.28 million, respectively. The company's operating cash flow is also negative at -$13.95 million, indicating that it is not generating sufficient cash from operations to sustain its activities. Modular Medical Inc's revenue is concentrated in a single business segment, as disclosed in its financial statements. The company does not provide detailed geographic revenue breakdowns, but its operations are primarily based in the United States. The lack of geographic diversification may expose the company to regional economic and regulatory risks. The company's growth trajectory is uncertain, as it has not provided specific revenue growth projections for the current or next fiscal year. The company's free cash flow is negative at -$4.62 million, and its capital expenditures are -$1.70 million, indicating that it is not investing in new projects or expanding its operations. The company's shares outstanding are the same for both basic and diluted shares, at 5.41 million, suggesting that there is no significant dilution risk from stock options or convertible securities. The company's risk assessment indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected. The company's liquidity position is strong, with a high current ratio and significant cash reserves. However, the company's negative operating and net income, along with its negative operating cash flow, may raise concerns about its long-term financial sustainability. The company has not made any recent public filings or disclosures that would indicate significant changes in its business or financial condition.
Key takeaways
  • Modular Medical Inc has a strong liquidity position with a current ratio of 6.66 and $9.23 million in cash and equivalents.
  • The company's profitability metrics are negative, with a return on equity of -37.11% and a return on assets of -31.01%.
  • The company's revenue is concentrated in a single business segment, and it does not provide detailed geographic revenue breakdowns.
  • The company's growth trajectory is uncertain, with no specific revenue growth projections provided for the current or next fiscal year.
  • The company's risk assessment indicates a low level of liquidity and dilution risk, with no immediate filing-based flags detected.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income-$4.3M
Net income-$4.3M
R&D
SG&A
D&A
SBC
Operating cash flow-$14.0M
CapEx-$1.7M
Free cash flow-$4.6M
Total assets$13.8M
Total liabilities$2.3M
Total equity$11.5M
Cash & equivalents$9.2M
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4-$7.3M-$7.4M-$7.4M
FY-3-$16.2M-$18.6M-$18.6M
FY-2-$13.9M-$13.9M-$15.4M
FY-1-$17.5M-$17.5M-$18.7M
FY0-$19.0M-$18.8M-$20.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$2.2M-$1.3M$1.5M
FY-3$9.8M$8.8M$9.1M
FY-2$7.2M$5.1M$3.8M
FY-1$13.8M$11.5M$9.2M
FY0$18.7M$17.1M$13.1M
PeriodOCFCapExFCFSBC
FY-4-$5.9M-$109.7k-$7.4M
FY-3-$10.3M-$54.8k-$18.6M
FY-2-$11.0M-$1.6M-$15.4M
FY-1-$14.0M-$1.7M-$18.7M
FY0-$15.7M-$2.5M-$20.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7-$4.3M-$4.3M-$4.6M
FQ-6-$4.2M-$4.1M-$4.8M
FQ-5-$5.0M-$5.0M-$4.9M
FQ-4-$4.9M-$4.8M-$5.1M
FQ-3-$5.0M-$4.9M-$5.5M
FQ-2-$6.8M-$6.7M-$7.2M
FQ-1-$7.8M-$7.8M-$8.2M
FQ0-$7.2M-$7.4M-$8.2M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$13.8M$11.5M$9.2M
FQ-6$10.1M$8.0M$5.1M
FQ-5$8.8M$6.9M$3.9M
FQ-4$12.1M$10.3M$7.0M
FQ-3$18.7M$17.1M$13.1M
FQ-2$14.2M$11.8M$7.5M
FQ-1$13.0M$8.8M$5.3M
FQ0$10.3M$5.9M$2.9M
PeriodOCFCapExFCFSBC
FQ-7-$14.0M-$1.7M-$4.6M
FQ-6-$3.5M-$842.0k-$4.8M
FQ-5-$7.3M-$1.0M-$4.9M
FQ-4-$11.4M-$1.5M-$5.1M
FQ-3-$15.7M-$2.5M-$5.5M
FQ-2-$5.4M-$934.0k-$7.2M
FQ-1-$10.8M-$1.7M-$8.2M
FQ0-$17.9M-$2.9M-$8.2M
Valuation
Market price$3.46
Market cap$18.7M
Enterprise value$9.5M
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B1.6
P/Tangible book1.6
Tangible book$11.5M
Net cash$9.2M
Current ratio6.7
Debt/Equity0.0
ROA-31.0%
ROE-37.1%
Cash conversion3.3%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricMODDActivity
Op margin3.9% medp25 -31.3% · p75 14.4%
Net margin2.4% medp25 -30.5% · p75 11.1%
Gross margin46.7% medp25 28.2% · p75 63.1%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.8% medp25 -11.6% · p75 -2.4%
Debt / equity0.0%17.9% medp25 2.7% · p75 52.2%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-17 01:14 UTC#60c4f026
Market quoteclose USD 3.95 · shares 0.01B diluted
no public URL
2026-05-17 01:14 UTC#ec17a522
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 15:04 UTCJob: d4c458b1